Drug
Mgd014
Mgd014: highest development phase Phase 1, developed by MacroGenics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- MacroGenics
Trials
| Drug | Phase | Indication |
|---|---|---|
| MGD014 NCT03570918 | Phase 1 | HIV-1-infection |
Latest
No recent events.
Follow Mgd014 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.